Hadassah

Hadassah Graduate Designs Programs That Decrease Death from HIV/AIDS and TB

Wednesday, Dec 18 2013

Benson Ulo, a 2003 graduate of the International Masters of Public Health Program at the Hadassah-Hebrew University Braun School of Public Health and Community Medicine, applauds his education for providing him with a “flexible think tank,” where students are equipped to shape public health care worldwide.

Having struggled to gain admittance to medical school, Mr. Ulo found himself forced to interrupt his education. He took on odd jobs at construction sites, just to survive. Three years later, he was fortunate to get a sponsor, which made it possible for him to return to academia to study public health. He subsequently received a scholarship to attend the IMPH program in Jerusalem. This was “an opportunity of a lifetime,” he says, “and has led to multiple rewards in my life.”

At international Medical Corps, his employer since 2004, Mr. Ulo says, his IMPH education has enabled him to design and implement HIV/AIDS and TB programs that have helped thousands of people, with both prevention and treatment in remote areas of his country. Mr. Ulo is currently the director of an HIV/AIDS and TB program in local prisons which, he reports, has greatly improved the health of inmates, bringing down the TB death rate from about 40 percent to zero!

Mr. Ulo shares his work experiences at international conferences and, as a result, believes he influences program design in many other countries.

 

 

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Aug 16 2017

Gazan Boy Walks for First Time at Hadassah

Unable to stand on his feet, suffering from severe respiratory distress, a four-year-old boy from Gaza gained the ability to walk once Hadassah Hospital surgeons identified and removed a large tumor lodged in his chest.

READ MORE ›
alt_text

Wednesday, Aug 16 2017

Hadassah Hosts Health Innovation Conference

Over one hundred doctors, researchers, and entrepreneurs gathered at Hadassah Hospital Ein Kerem this summer to discuss how to advance the quality of patient care with computational power.

READ MORE ›
alt_text

Monday, Aug 14 2017

Hadassah Hosts First Human Trial with Drug to Fight Nasty Bacterial Infection

Immuron, an Australian biopharmaceutical company, has received approval from the Hadassah Medical Organization’s ethics committee and Israel’s Ministry of Health to begin its first clinical trial with a new drug to fight a bacterial infection called Clostridium Difficile (CDI).

READ MORE ›
alt_text

Thursday, Aug 3 2017

Mystery of Devastating Pediatric Disease Solved by Hadassah Team

A genetic mutation causing a rare and devastating pediatric neurological disease that has puzzled medical centers around the world has been identified at the Hadassah Medical Organization by Prof. Orly Elpeleg, head of Hadassah's Department of Genetics and Metabolic Diseases.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More